Reviving Blood Testing: Lessons from Theranos

4min Snip

00:00

Play full episode

Summary

Transcript

Episode notes

This chapter explores the renewed focus on blood testing technologies inspired by the rise and fall of Theranos. It highlights how companies are leveraging lessons from Theranos' failures to create more efficient and less invasive testing methods, ultimately spurring innovation in medical diagnostics.

Episode 377: Neal and Toby discuss whether investors are right to be concerned about the massive AI expenditures being made with little to no revenue to show for it. Then, the US Senate just passed the Kids Online Safety Act to force tech companies to have stricter online rules for teens. Next, Starbucks misses its earnings expectations as same-store traffic continues to fall in the US and around the world. Plus, a number of startups are doing what Theranos wanted to do… minus the whole fraud part. Meanwhile, perhaps the failed JetBlue-Spirit merger was actually a good thing? Lastly, the latest news and stories from the 2024 Paris Olympics.

Checkout https://beehiiv.link/morning-brew-daily and get a 30 day free trial and also 20% off 3 months with code BREW

Get your Morning Brew Daily T-Shirt HERE: https://shop.morningbrew.com/products/morning-brew-radio-t-shirt?_pos=1&_sid=6b0bc409d&_ss=r&variant=45353879044316

Listen to Morning Brew Daily Here: https://link.chtbl.com/MBD

Watch Morning Brew Daily Here: https://www.youtube.com/@MorningBrewDailyShow

Learn more about your ad choices. Visit megaphone.fm/adchoices